LLMpediaThe first transparent, open encyclopedia generated by LLMs

Stanford University Office of Technology Licensing

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: SRI International Hop 2
Expansion Funnel Raw 71 → Dedup 17 → NER 17 → Enqueued 1
1. Extracted71
2. After dedup17 (None)
3. After NER17 (None)
4. Enqueued1 (None)
Similarity rejected: 8
Stanford University Office of Technology Licensing
NameStanford University Office of Technology Licensing
Established1970s
LocationStanford, California
ParentStanford University

Stanford University Office of Technology Licensing The Office of Technology Licensing (OTL) at Stanford University is the university unit responsible for managing intellectual property, patenting, licensing, and technology transfer arising from research at Stanford University. Founded during the rise of university commercialization in the late 20th century, OTL has played a central role in translating innovations from campus laboratories into startups and licensed products involving partners such as Hewlett-Packard, Google, Genentech, Agilent Technologies, and Cisco Systems. The office interacts frequently with entities including National Institutes of Health, National Science Foundation, U.S. Patent and Trademark Office, Silicon Valley Bank, and venture capital firms like Sequoia Capital and Kleiner Perkins.

History

OTL traces origins to broader technology transfer movements exemplified by the Bayh–Dole Act and institutional precedents at University of Wisconsin–Madison, Columbia University, and Massachusetts Institute of Technology. During the 1970s and 1980s the office navigated landmark cases and collaborations with corporations including Hewlett-Packard and pharmaceutical concerns such as Genentech and Amgen. The 1990s and 2000s saw OTL engage with startups linked to founders from Yahoo!, Sun Microsystems, Netscape, and Cisco Systems, while managing patents related to breakthroughs connected to researchers who later participated in ventures with Google and Facebook. OTL’s evolution paralleled policy debates involving United States v. Microsoft antitrust proceedings and legislative dialogue with lawmakers in United States Congress regarding university licensing practices.

Organization and Leadership

The office is structured with licensing officers, patent counsel, business development staff, and operations support, working alongside campus units such as the Stanford School of Medicine, Stanford School of Engineering, Stanford Graduate School of Business, and research centers including Stanford Linear Accelerator Center and SLAC National Accelerator Laboratory. Senior leaders have included technology licensing executives recruited from organizations like IBM, Merck, Intel, and GlaxoSmithKline, and collaborate with academic figures such as deans and principal investigators formerly affiliated with Nobel Prize laureates, recipients of the MacArthur Fellowship, and members of the National Academy of Sciences. Governance aligns with the Board of Trustees of Stanford University policies and legal frameworks under the U.S. Constitution commerce clause as interpreted by federal courts.

Mission and Activities

OTL’s mission integrates patent prosecution, licensing negotiations, startup formation, equity management, and compliance with sponsored research agreements from funders such as National Institutes of Health, Defense Advanced Research Projects Agency, Bill & Melinda Gates Foundation, and Howard Hughes Medical Institute. Activities include evaluating disclosures from researchers affiliated with laboratories led by faculty formerly associated with Kavli Institute for Particle Astrophysics and Cosmology, coordinating material transfer agreements involving institutions like Cold Spring Harbor Laboratory and Lawrence Berkeley National Laboratory, and managing confidentiality under guidelines informed by decisions from the U.S. Court of Appeals for the Federal Circuit. OTL also provides training and outreach to investigators in schools including Stanford Law School and Stanford Medicine on issues related to licensing and conflict of interest.

Major Innovations and Notable Licenses

OTL has overseen commercialization of inventions linked to technologies such as recombinant DNA that intersected with companies like Genentech and advances in semiconductor design tied to founders of Intel and NVIDIA. Notable licenses include foundational patents that contributed to the formation or growth of firms associated with Google, Yahoo!, VMware, Synopsys, and Thermo Fisher Scientific. The office managed rights related to biomedical discoveries that interfaced with Amgen, Pfizer, Roche, and diagnostics collaborations reaching organizations like Abbott Laboratories and Siemens Healthineers. OTL’s portfolio has included software, hardware, biomedical, and energy technologies with links to inventions stemming from laboratories connected to prizes such as the Turing Award and Lasker Award.

Partnering and Industry Relations

OTL maintains strategic relationships with corporate partners including Cisco Systems, Hewlett-Packard, Intel, Adobe Systems, and pharmaceutical partners like Genentech and Merck; financial and investment relationships involve entities such as Sequoia Capital, Accel Partners, and Andreessen Horowitz. The office negotiates sponsored research agreements and collaborative research with industrial research labs like Bell Labs and Xerox PARC, and coordinates workforce and entrepreneurship pathways with accelerators and incubators including Y Combinator and Plug and Play Tech Center. International partnerships engage organizations such as the European Commission, Japan Science and Technology Agency, and university tech transfer offices at University of Cambridge and University of Oxford.

Revenue, Impact, and Metrics

OTL reports metrics including license income, startup formation counts, patent filings, and equity holdings that have contributed to university revenues and endowment growth overseen by the Stanford Management Company. Revenue streams have arisen from successful exits through mergers and acquisitions involving firms like Google (in its early-stage investment history), biotech acquisitions by Roche and Amgen, and IPOs supported by venture firms such as Kleiner Perkins and Goldman Sachs. Impact assessments reference economic development in Silicon Valley, job creation tied to firms spun out from campus research, and citations in policy discussions by agencies including the National Academies of Sciences, Engineering, and Medicine regarding best practices in university technology transfer.

Category:Stanford University